Mechanistic studies revealed that MUC1 reduced NLRP3 inflammasome-mediated pyroptosis by inhibiting TLR4/MyD88/NF-κB pathway activation, thereby suppressing neutrophilic airway inflammation in patients with asthma. Here, NLRP3 is linked to asthma.